Live Events
This Women’s History Month, Retail Refined’s host joined The DealMakeHers for a series of transformative moments — from opening and closing the Nasdaq to sharing an intimate tea with trailblazer Gloria Steinem. Across several days of meaningful conversations and landmark events, we celebrated women’s leadership, innovation, and resilience. Here’s a recap: Opening Nasdaq For…
Latest
Live Events
The Digitization of Offline Retail: Taking Your Store Online
MarketScale’s Retail Refined, with host Melissa Gonzalez, is leading the discussion around retail in the new normal and beyond — and it’s going live. On this live episode, Gonzalez will be joined by Radius8 CEO and Founder Sandeep Bhanote, DeepNorth AI CEO and Co-Founder Rohan Sanil and Pilot Consulting Founder Ken Pilot, who will…
Latest
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…
What’s Next in Preclinical Cancer Immunotherapy Research?
As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
